Research Paper Volume 15, Issue 21 pp 12192—12208

N7-methylguanosine-related miRNAs predict hepatocellular carcinoma prognosis and immune therapy

class="figure-viewer-img"

Figure 6. Survival analysis of the prognostic value of the miRNA candidates in HCC patients. (A) hsa-miR-195-5p, (B) hsa-miR-152-5p, and (C) hsa-miR-9-5p.